Company Filing History:
Years Active: 2015
Title: Innovations of Matthew Ficinski in Optogenetic Treatment
Introduction
Matthew Ficinski is an innovative inventor based in Baldwin Park, CA (US). He has made significant contributions to the field of optogenetics, particularly in the treatment of blindness caused by conditions such as retinitis pigmentosa. His work focuses on developing methods and apparatuses that enhance the delivery of genetic material to retinal cells.
Latest Patents
Ficinski holds a patent for a groundbreaking invention titled "Method and apparatus for optogenetic treatment of blindness including retinitis pigmentosa." This patent describes an apparatus designed for in vivo electroporating a plasmid into the retina of any eye. The apparatus includes a first electrode with a first polarity of voltage placed in contact with the cornea of the eye, and a second electrode with an opposite second voltage positioned behind the retina. The invention utilizes a pulsed voltage source to provide a pulsed DC voltage optimized for transfection of the channelrhodopsin-2 (ChR2) gene into retinal ganglion cells. This method allows for non-viral delivery of the ChR2 gene, facilitating the treatment of retinal ganglion cells without the use of viral transfection.
Career Highlights
Matthew Ficinski is affiliated with the University of California, where he continues to advance his research in optogenetics. His work has the potential to revolutionize treatments for various forms of blindness, providing hope to many individuals affected by these conditions. With 1 patent to his name, Ficinski is recognized for his innovative approach to addressing complex medical challenges.
Collaborations
Ficinski collaborates with esteemed colleagues, including Samarenda K Mohanty and Edward K Wong. Their combined expertise contributes to the advancement of research in the field of optogenetics and enhances the potential for successful treatments.
Conclusion
Matthew Ficinski's contributions to the field of optogenetics exemplify the power of innovation in addressing critical health issues. His patented methods and collaborative efforts are paving the way for new treatments that could significantly improve the quality of life for individuals suffering from blindness.